original ) (raw )Clinical Outcomes of Tenofovir Versus Zidovudine-based Regimens Among People Living with HIV/AIDS: a Two Years Retrospective Cohort Study
Teshale Ayele
The open AIDS journal, 2017
View PDFchevron_right
Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults
BRIGHT B BOAMAH , Stephen Arhin
View PDFchevron_right
Comparison of Zidovudine Combination and Tenofovir Combination on the Effectiveness of Therapy and Side Effects in Hiv/Aids Patients in Rsal Mintohardjo
Retnosari Andrajati
Asian Journal of Pharmaceutical and Clinical Research, 2017
View PDFchevron_right
Immuno-virological status and its associated factors among HIV-positive patients receiving highly active antiretroviral therapy at delgi primary hospital, northwest Ethiopia, 2020/2021: A cross-sectional study
Tahir Eyayu
Heliyon
View PDFchevron_right
Trends of Immuno-virological Response Among HIV-Infected Patients Receiving Highly Active Anti-retroviral Therapy at Hawassa, Southern Ethiopia
Agete Tadewos
Clinical Medicine Research, 2015
View PDFchevron_right
Treatment outcomes of tenofovir versus zidovudine-based first-line antiretroviral therapy regimens at Zewditu Memorial Hospital: A retrospective cohort study
mamo feyissa
Journal of AIDS and HIV Research, 2020
View PDFchevron_right
Toxicity and clinical outcomes in patients with HIV on zidovudine and tenofovir based regimens: a retrospective cohort study
S. Pulimood
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2015
View PDFchevron_right
Tenofovir-Emtricitabine-Efavirenz in HIV-I-Infected Adults in Senegal: A 96-Week Pilot Trial in Treatment-Naive Patients
Dr Halimatou DIOP
Journal of the International Association of Physicians in AIDS Care (JIAPAC), 2009
View PDFchevron_right
Superior effectiveness of zidovudine compared to tenofovir when combined with nevirapine-based antiretroviral therapy in a large Nigerian Cohort
Wadzani Gashau
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015
View PDFchevron_right
Predictors of Immunological Failure of Antiretroviral Therapy among HIV Infected Patients in Ethiopia: A Matched Case-Control Study
Anteneh Asefa , Wondu Teshome
PLoS ONE, 2014
View PDFchevron_right
Comparison of Zidovudine and Tenofovir Based Regimens With Regard to Health-Related Quality of Life and Prevalence of Symptoms in HIV Patients in a Kenyan Referral Hospital
Faith Apolot Okalebo
Frontiers in Pharmacology, 2018
View PDFchevron_right
Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia
Bobs Mulenga
Journal of acquired …, 2010
View PDFchevron_right
Factors associated with immunological and virological discordant responses to highly active antiretroviral therapy among adult HIV positive individuals in Ethiopia
Milkias Abebe
Medicine, 2021
View PDFchevron_right
Comparative Outcomes of Tenofovir-Based and Zidovudine-Based Antiretroviral Therapy Regimens in Lusaka, Zambia
Izukanji Sikazwe
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
View PDFchevron_right
Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial
Roland Landman
Antiviral Therapy, 2013
View PDFchevron_right
Immunohematological Outcome Among Adult HIV Patients Taking Highly Active Antiretroviral Therapy for at Least Six Months in Yabelo Hospital, Borana, Ethiopia
Girma Ashenafi
Journal of Blood Medicine
View PDFchevron_right
Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya
Emmanuel Kemboi
Journal of the International AIDS Society, 2016
View PDFchevron_right
Rate of Immunological Failure and its Predictors among Patients on Highly Active Antiretroviral Therapy at Debremarkos Hospital, Northwest Ethiopia: A Retrospective Follow up Study
Yayehirad Alemu , Gizachew Tessema
Journal of AIDS & Clinical Research, 2013
View PDFchevron_right
Immunological responses of HIV/AIDS patients treated with Nevirapine versus Efavirenz based highly active anti-retroviral therapy in Addis Ababa, Ethiopia: A retrospective cohort study
Mesfin Debere
View PDFchevron_right